Invitae Corp fetches $40 mln in Series E financing

Invitae Corp. has closed $40 million in Series E financing. Investors included Genomic Health, Randy Scott, Thomas McNerney & Partners, Redmile Group, Genesys Capital and Casdin Capital. Based in San Francisco, Invitae is a genetic diagnostics company that specializes in hereditary disorders.

North AmericaUSBriefs